BPA Call 36C24123A0080-36C24124N0007
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $1.54 million by Veterans Integrated Service Network (VISN) 1 for immunochemistry clinical laboratory testing services. The award, issued on October 1, 2024, with an ultimate completion date of September 30, 2025, represents a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Master Schedule. This BPA call includes...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $4.3 million by Veterans Integrated Service Network (VISN) 1, effective October 1, 2024, with an ultimate completion date of September 30, 2025. This firm fixed-price contract, which includes holiday service coverage expansion, supports immunochemistry clinical pathology reference range (CPRR) testing services at the VA facility in Boston, Massachusetts. The contract...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $3.68 million for chemistry testing services to Veterans Integrated Service Network 1 (VISN 1), an operational unit of the Department of Veterans Affairs. Issued on October 1, 2023, with an ultimate completion date of September 30, 2024, this firm fixed-price contract was awarded without set-aside designation, indicating full and open competition. The contract is...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $1.44M by Veterans Integrated Service Network (VISN) 15, a component of the Department of Veterans Affairs. The contract, awarded on August 1, 2023, with an ultimate completion date of July 31, 2024, covers cost per reportable results and automation equipment. This award represents a call against Abbott's existing Critical Analyzers, Laboratory...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $341,218.20 by Veterans Integrated Service Network 4 (VISN 04) for chemistry testing services. The contract, which operates under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Master Schedule, carries a firm fixed-price structure and does not utilize any set-aside designation, indicating full and open competition. The place of...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a $1.52M firm fixed-price blanket purchase agreement (BPA) call for automated chemistry and immunochemistry instrumentation by Veterans Integrated Service Network 23 (VISN 23), a civilian component of the Department of Veterans Affairs. The contract, which commenced on October 1, 2023, with an ultimate completion date of September 30, 2024, was awarded without set-aside designation, indicating full and open...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call valued at $33,769 by Veterans Integrated Service Network 23 (VISN 23) for chemistry laboratory reagents and related products. The award, issued on October 1, 2025, with an ultimate completion date of December 31, 2025, operates under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) master contract schedule. This procurement was awarded without...
- Abbott Laboratories Inc.'s Abbott Diagnostics Division was awarded a Blanket Purchase Agreement (BPA) call valued at $1.52 million by Veterans Integrated Service Network 4 (VISN 04) on September 1, 2024, for chemistry testing services. This contract utilizes a firm fixed-price structure and is not set-aside designated, indicating full and open competition. The award is structured as a call against a larger parent contract under the General Services Administration's Critical Analyzers, Laboratory...
- The U.S. Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) call to Abbott Laboratories Inc., through its Abbott Diagnostics Division, valued at $1,049,856.79. The contract is for the provision of immunoassay cost-per-reportable result services and is being issued under Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers and Laboratory equipment. The contract has a period of performance through...
- Abbott Laboratories Inc., through its Abbott Diagnostics Division, has been awarded a Blanket Purchase Agreement (BPA) call valued at $498,580.80 for VISN 04 Chemistry Testing services. This contract, awarded on September 1, 2025, with an ultimate completion date of August 31, 2026, will be performed in Aspinwall, Pennsylvania. The award represents a firm fixed-price contract issued without set-aside designation, indicating full and open competition. This BPA call is issued under the General...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- 36F79719D0024-36C24123A0080Blanket Purchase Agreement
- 36C24123A0080-36C24124N0007BPA Call
Abbott Laboratories Inc., through its Abbott Diagnostics Division, received a $1.25 million Blanket Purchase Agreement (BPA) call award from Veterans Integrated Service Network (VISN) 1 for immunochemistry CPRR (Cardiac Protein Rapid Response) testing services. The contract, awarded October 1, 2023, with a completion date of September 30, 2024, operates under a firm fixed-price structure with no set-aside designation, indicating full and open competition. The award falls under the parent General Services Administration Critical Analyzers, Laboratory (FSS-66-III) schedule, which streamlines federal procurement of advanced diagnostic laboratory equipment and services. Performance will be conducted at Abbott's North Chicago, Illinois facility. This BPA call supports critical clinical laboratory operations within the VA healthcare system, providing specialized immunochemistry testing capabilities essential to VISN 1's medical service delivery. Abbott Laboratories has established itself as a strategic supplier of diagnostic testing services across multiple VA Integrated Service Networks, with a robust portfolio of immunochemistry and clinical chemistry contracts. The firm fixed-price mechanism and full and open competition designation reflect standard federal procurement practices for medical diagnostic services within established GSA schedule frameworks, enabling the VA to efficiently access specialized testing capabilities while maintaining competitive market conditions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($136k) | 4/18/25 | |
| P00001 | Supplemental Agreement for work within scope | ($120k) | 8/8/24 | |
| Not listed | Not listed | $1.5m | 10/1/23 |